Skip to main content
SpringerLink
Log in

New Devices and Hybrid Therapies and New Devices for Treatment of Atrial Fibrillation

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1991;22:983–988.

    Google Scholar 

  2. Kannel WB, Abbot RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Eng J Med 1982;306:1018–1022.

    Google Scholar 

  3. Anderson JL, Gilber EM, Alpert BI, et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. Circulation 1989;80:1557–1570.

    Google Scholar 

  4. Pritchett ELC, McCarthy EA, Wilkinson WE. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med 1991;114:539–544.

    Google Scholar 

  5. Coplen SE, Antman AM, Berlin JA, Hewitt P, Chaimers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation 1990;82:1106–1116.

    Google Scholar 

  6. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG, on behalf of the Stroke Prevention in Atrial Fibrillation Investigators. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527–532.

    Google Scholar 

  7. Levy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992;86:1415–1420.

    Google Scholar 

  8. Alt E, Schmitt C, Ammer R, et al. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994;17:1067–1078.

    Google Scholar 

  9. Bianconi L, Mennuni M, Lukic V, Castro M, Chieffi M, Santini M. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation. A placebo-controlled trial. J Am Coll Cardiol 1996;28:700–706.

    Google Scholar 

  10. Saksena S, Prakash A, Mongeon L, et al. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 1995;76:913–921.

    Google Scholar 

  11. Murgatroyd FD, Slade AKB, Sopher M, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995;25:1347–1353.

    Google Scholar 

  12. Levy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997;29:750–755.

    Google Scholar 

  13. Ayers GM, Alferness CA, Ilina M, et al. Ventricular prorrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994;89:413–422.

    Google Scholar 

  14. Mohan N, Saoudi N, Kroiss D, Letac B, for the Participating Centers of the Automatic Recognition of Arrhythmia Study Group. Automatic arrhythmia identification using analysis of the atrioventricular association. Application to a new generation of implantable defibrillators. Circulation 1997;95:967–973.

    Google Scholar 

  15. Lavergne T, Daubert JC, Chauvin M, et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997;20:182–188.

    Google Scholar 

  16. Reiter MJ, Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1996;7:542–558.

    Google Scholar 

  17. Wellens HJJ, Lau C-P, Luderitz B, et al. Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651–1656.

    Google Scholar 

  18. Wijffels MCEF, Kirchhof CJHJ, Dorland RD, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954–1968.

    Google Scholar 

  19. Timmermans C, Wellens HJJ, for the Metrix Investigators. Effect of device-mediated therapy on symptomatic episodes of atrial fibrillation. J Am Coll Cardiol 1998;31:331A (Abstract).

    Google Scholar 

  20. Lok N-S, Lau C-P, Tse HF, Ayers GM. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997;30:1324–1330.

    Google Scholar 

  21. Jung J, Heisel A, Fries R, Kollner V. Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion. Am J Cardiol 1997;80:1489–1490.

    Google Scholar 

  22. Ammer R, Alt E, Ayers G, Schmitt C, Pasquantonio J, Schmitt M, Putter K, Schomig A. Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. PACE 1996;19:230–236.

    Google Scholar 

  23. Tomassoni G, Newby KH, Kearney MM, Brandon MJ, Barold H, Natale A. Testing different biphasic waveforms and capacitances: effect on atrial defibrillation threshold and pain perception. J Am Coll Cardiol 1996;28:695–699.

    Google Scholar 

  24. Kumagai K, Yamanouchi T, Tashiro N, Hiroki T, Arakawa K. Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog. J Am Coll Cardiol 1990;16:497–501.

    Google Scholar 

  25. Strickberger S, Labhasetwar V, Davis J, Underwood T, Levy R. Reduced defibrillation thresholds with endocardial administration of artilide. J Am Coll Cardiol 1996;27:265A (Abstract).

    Google Scholar 

  26. Newby K, Waugh R, Hardee M, Henderson P, Mertz J. Amiodarone decreases defibrillation threshold in patients undergoing elective cardioversion for atrial defibrillation. Circulation 1996;94:I-666.

    Google Scholar 

  27. Mongeon L, Hill M, Mehra R. Procainamide decreases atrial defibrillation requirements in sustained atrial fibrillation conditioned canines. Circulation 1996;94:I-136-I-137.

    Google Scholar 

  28. Huang DT, Monahan KM, Zimetbaum P, Papageorgiou P, Epstein LM, Josephson ME. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:462–469.

    Google Scholar 

  29. Nabar A, Rodriquez LM, Timmermans C, Smeets JI, Wellens H. Radiofrequency ablation of “class IC atrial flutter” in patients with resistant atrial fibrillation. Am J Cardiol 1999;83:785–787.

    Google Scholar 

  30. Elvan A, Pride HP, Eble JN, Zipes DP. Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. Circulation 1995;91:2235–2244.

    Google Scholar 

  31. Kalman J, Olgin J, Karch M, et al. Effect of right atrial linear lesions on atrial defibrillation threshold. Implications for hybrid therapy. PACE 1996;19(II):625 (Abstract).

    Google Scholar 

  32. Olgin J, Kalman J, Maguire M, Chin M, Stillson C. Lesh M. Electrophysiologic effects of long linear atrial lesions placed under intracardiac echo guidance PACE 1996;19(II):581

    Google Scholar 

  33. Ellenbogen KA, Hawthorme HR, Belz MK, Stambler BS, Cherwek ML, Wood MA. Late occurrence of incessant atrial tachycardia following the maze procedure. PACE 1995;18:367–369.

    Google Scholar 

  34. Garson A, Bink-Boelkins M, Hesslein PS, et al. Atrial flutter in the young: A collaborative study of 380 cases. J Am Coll Cardiol 1985;6:871–878.

    Google Scholar 

  35. Feld GK, Fleck RP, Chen PS, et al. Radiofrequency catheter ablation for the treatment of type I atrial flutter. Identification of a critical zone in the reentry circuit by endocardial mapping techniques. Circulation 1992;86:1233–1240.

    Google Scholar 

  36. Poty H, Saoudi N, Abdel Aziz A, et al. Radiofrequency catheter ablation of type 1 atrial flutter. Prediction of late success by electrophysiological criteria. Circulation 1995;92:1389–1392.

    Google Scholar 

  37. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991;101:408–426.

    Google Scholar 

  38. Swartz JF, Pellersels G, Silvers J, et al. A catheter-based curative approach to atrial fibrillation in humans. Circulation 1994;90(Part 2):1–335 (Abstract).

    Google Scholar 

  39. Haissaguerre M, Jais P, Shah DC, et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996;12:1132–1144.

    Google Scholar 

  40. Jais P, Haissaguerra M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572–576.

    Google Scholar 

  41. Ching Man K, Daoud E, Knight B, et al. Right atrial-radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Am Coll Cardiol 1996;27:188A (Abstract).

    Google Scholar 

  42. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PEB. Prospective randomized trial of atrial versus ventricular pacing in sick sinus syndrome. Lancet 1994;344:1523–1528.

    Google Scholar 

  43. Coumel P, Friocourt P, Mugica J, Attuel P, LeClercq JF. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: Experience with 6 cases. PACE 1983;6:552–560.

    Google Scholar 

  44. Daubert C, Mabo P, Berder V, et al. Arrhythmia prevention by permanent atrial resynchronisation in advanced interatrial block. Eur Heart J 1990;11:237 (Abstract).

    Google Scholar 

  45. Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing. J Am Coll Cardiol 1996;26:687–694.

    Google Scholar 

  46. Murgatroyd F, Hnatkova K, Baiyan X, Camm AJ, Malik M. Mode of onset of spontaneously occurring episodes of atrial fibrillation. PACE 1993;16:1927 (Abstract).

    Google Scholar 

  47. Saksena S, Giorgberidze I, Prakash A, et al. Endocardial mapping during induced atrial fibrillation. Circulation 1996;94:I-555 (Abstract).

    Google Scholar 

  48. Prakash A, Hill M, Lewis C, et al. Comparative efficacy of high right, coronary sinus and dual site right atrial pacing in prevention of atrial fibrillation. PACE 1996;19(II):634 (Abstract).

    Google Scholar 

  49. Papageorgiou P, Monahan K, Boyle NG, et al. Site-dependent intra-atrial conduction delay: Relationship to initiation of atrial fibrillation. Circulation 1996;94:384–389.

    Google Scholar 

  50. Prakash A, Saksena S, Krol R, Delfaut P. Mathew P. Nonphamacologic therapy provides an effective long-term rhythm control in patients with atrial fibrilation. Arch Mal Coeur 1998;91:172 (Abstract).

    Google Scholar 

  51. Prakash A, Delfaut P, Krol R, Mathew P, Saksena S. Management of frequent recurrent atrial fibrillation/flutter with hybrid nonpharmacologic therapy. Arch Mal Coeur 1998;91:336 (Abstract).

    Google Scholar 

  52. Prakash A, Krol RB, Saksena S, Sumar R. Ablation of coexisting atrial flutter elicited using an electrophysiologic strategy in atrial fibrillation improves drug efficacy in refractory patients. PACE 1999;22(I):743(abstract).

    Google Scholar 

  53. Dell'Orfano JT, Hemantkumar P, Wolbrette DL, Luck JC, Naccarelli GV, Acute treatment of atrial fibrillation: Spontaneous conversion rates and cost of care. Am J Cardiol 1999;83:788–790.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eastern Heart Institute—Atlantic Health System, Passaic, New Jersey

    Ryszard B. Krol, Sanjeev Saksena & Atul Prakash

Authors
  1. Ryszard B. Krol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjeev Saksena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atul Prakash
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krol, R.B., Saksena, S. & Prakash, A. New Devices and Hybrid Therapies and New Devices for Treatment of Atrial Fibrillation. J Interv Card Electrophysiol 4 (Suppl 1), 163–169 (2000). https://doi.org/10.1023/A:1009875832060

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009875832060

Keywords

Search

Navigation